PROGNOSTIC IMPACT OF P53 EXPRESSION IN BONE MARROW BIOPSY OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Souza, H. [1 ]
Saad, S. [1 ]
Lorand-Metze, I. [1 ]
Duarte, B. [1 ]
Hayakawa, G. [1 ]
Campos, P. [1 ]
Delamain, M. [1 ]
Duarte, G. [1 ]
Vassallo, J. [1 ]
Pagnano, K. [1 ]
机构：
[1] Univ Estadual Campinas, Campinas, SP, Brazil
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1674
引用
收藏
页码：675 / 676
页数：2
相关论文
共 50 条
  • [21] Expression and prognostic impact of lncRNAs in acute myeloid leukemia
    Garzon, Ramiro
    Volinia, Stefano
    Papaioannou, Dimitrios
    Nicolet, Deedra
    Kohlschmidt, Jessica
    Yan, Pearlly S.
    Mrozek, Krzysztof
    Bucci, Donna
    Carroll, Andrew J.
    Baer, Maria R.
    Wetzler, Meir
    Carter, Thomas H.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Moore, Joseph O.
    Eisfeld, Ann-Kathrin
    Blachly, James S.
    Blum, William
    Caligiuria, Michael A.
    Stone, Richard M.
    Marcucci, Guido
    Croce, Carlo M.
    Byrd, John C.
    Bloomfield, Clara D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (52) : 18679 - 18684
  • [22] The Functional and Prognostic Impact of TIGIT Expression on Bone Marrow NK Cells in Core Binding Factor-Acute Myeloid Leukemia Patients at Diagnosis
    Xie, Dai-Hong
    Wang, Jun
    Sun, Kai
    Shi, Zong-Yan
    Wang, Ya-Zhe
    Chang, Yan
    Yuan, Xiao-Ying
    Liu, Yan-Rong
    Jiang, Hao
    Jiang, Qian
    Huang, Xiao-Jun
    Qin, Ya-Zhen
    BIOMEDICINES, 2024, 12 (10)
  • [23] p53 alterations in myeloid leukemia
    Boyapati, A
    Kanbe, E
    Zhang, DE
    ACTA HAEMATOLOGICA, 2003, 111 (1-2) : 100 - 106
  • [24] Targeting Misfolded p53 and p53 Aggregation to Overcome Resistance to Apoptosis in Acute Myeloid Leukemia
    Andreeff, Michael
    Zeng, Jianfang
    Soragni, Alice
    Ruvolo, Vivian
    Carter, Bing Z.
    Ishizawa, Jo
    Burks, Jared K.
    Eisenberg, David
    BLOOD, 2019, 134
  • [25] Analysis of p53 Expression in 84 Cases of Acute Myeloid Leukemia (AML) With Correlation With p53 Mutational Status and AML Subtype
    Fernandez-Pol, Sebastian
    Ma, Lisa
    Ohgami, Robert
    Arber, Daniel
    MODERN PATHOLOGY, 2015, 28 : 344A - 344A
  • [26] High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
    Quintas-Cardama, Alfonso
    Qiu, Yi Hua
    Post, Sean
    Kornblau, Steven M.
    BLOOD, 2011, 118 (21) : 646 - 647
  • [27] High p53 Protein Expression LEVEL Independent Of Mutational Status Is An Adverse Prognostic Factor For Survival In ACUTE Myeloid Leukemia
    Quintas-Cardama, Alfonso
    Post, Sean M.
    Kojima, Kensuke
    Qiu, Yi Hua
    Andreeff, Michael
    Bueso-Ramos, Carlos E.
    Kornblau, Steven M.
    BLOOD, 2013, 122 (21)
  • [28] Analysis of p53 Expression in 84 Cases of Acute Myeloid Leukemia (AML) With Correlation With p53 Mutational Status and AML Subtype
    Fernandez-Pol, Sebastian
    Ma, Lisa
    Ohgami, Robert
    Arber, Daniel
    LABORATORY INVESTIGATION, 2015, 95 : 344A - 344A
  • [29] Prognostic impact of P53 expression in oesophageal adenocarcinoma
    Coats, M. V.
    Walsh, S. V.
    Baker, L.
    Jordan, L.
    Thompson, A. M.
    Exon, D. J.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 24 - 25
  • [30] The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients
    Uenal, Sule
    Cetin, Mualla
    Tuncer, A. Murat
    Guemruek, Fatma
    Yetgin, Sevgi
    TURKISH JOURNAL OF PEDIATRICS, 2008, 50 (06) : 533 - 536
12345